KEB Asset Management’s Pfizer PFE Stock Holding History

KEB Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.1K	Buy	+1,084	New	+$28.4K	﹤0.01%	117
2023 Q2	–	Sell	-5,039	Closed	-$206K	–	64
2023 Q1	$206K	Hold	5,039	–	–	0.09%	58
2022 Q4	$258K	Sell	5,039 -57	-1%	-$2.73K	0.14%	48
2022 Q3	$223K	Buy	5,096 +57	+1%	+$2.77K	0.14%	49
2022 Q2	$264K	Hold	5,039	–	–	0.17%	42
2022 Q1	$261K	Sell	5,039 -31	-0.6%	-$1.61K	0.17%	37
2021 Q4	$299K	Buy	+5,070	New	+$251K	0.19%	36

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

KEB Asset Management's PFE Position: Q2 2026 in Review

KEB Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 1,084 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #117 among its holdings. This is a return to the name: KEB Asset Management previously reported a position in PFE as recently as Q1 2023.

KEB Asset Management first reported a position in PFE in Q4 2021 and has held it in 7 quarters since. The position peaked at $299K in Q4 2021. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

KEB Asset Management held 1,084 shares of Pfizer worth $26.1K as of Q2 2026.
Pfizer was a new KEB Asset Management position in Q2 2026.
Pfizer made up ﹤0.01% of KEB Asset Management's portfolio in Q2 2026, its #117 holding.
KEB Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 7 quarters since.
KEB Asset Management's Pfizer position peaked at $299K in Q4 2021.
557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on KEB Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.